is tirzepatide safer than semaglutide vs. Semaglutide: What You Should Know Are Compounded Semaglutide and Tirzepatide

Related Weight Loss Research Compounds Semaglutide 20mg GLP-1 Receptor Agonist Tirzepatide 30mg Dual GLP-1/GIP Agonist Retatrutide 20mg Triple Agonist Research Peptide Retatrutide 30mg Triple Agonist Research Peptide AOD-9604 5mg Fat-Metabolism Research Fragment Scientific References Jastreboff et al

The bottom line on this debate If you can access and afford brand-name GLP-1 medications through insurance, they are the safer choice from a regulatory standpoint

As of early 2026, retatrutide is still in Phase 3 clinical trials

Glucagon receptor activation, on the other hand, stimulates hepatic glucose output but also promotes lipid oxidation and thermogenesis [48]

& Korsmeyer, S

The recommended starting dose in patients not currently treated with metformin is 50 mg sitagliptin and 500 mg metformin HCl twice daily, with gradual dose escalation recommended to reduce gastrointestinal side effects associated with metformin